Current Status of Monoclonal Antibodies-Based Therapies in Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis of Clinical Trials

Overview

cited authors

Tarrar, Talha Azam; Anwar, Muhammad Yasir; Ali, Muhammad Ashar; Saeed, Memoona; Rehman, Sana; Bajwa, Shammas F.; Ayub, Tooba; Javid, Haleema; Ali, Rimsha; Irshad, Alaa; Aiman, Wajeeha

authors

Bajwa, Shammas, MD

Publication Date

March 7, 2022

webpage

Web of Science

published in

CUREUS Journal

Research

keywords

castration-resistant prostate cancer
checkpoint inhibitors
meta-analysis
monoclonal antibodies
prostate cancer
systematic review

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.